NCT Number: NCT00245921
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
To evaluate the safety and contraceptive efficacy of an oral contraceptive containing a combination of LNG 90 mg/EE 20 mg in a continuous-use regimen.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–49 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy women aged 18 to 49 years
- Regular (21- to 35- day) menstrual cycles for the 3-month period preceding visit 1
- Must be sexually active and at risk for becoming pregnant.
Exclusion criteria
- Planned use of any other form of birth control other than the test article.
- Depression requiring hospitalization or associated with suicidal ideation within the last 3 years.
- High blood pressure (defined as elevated sitting blood pressure: > 140/90 mm Hg).
Treatment and study plan
Primary outcomes
-
To evaluate safety and contraceptive efficacy
Secondary outcomes
-
To evaluate the effects of this LNG/EE combination on bleeding profile, endometrial histology, hemostasis measures, hemoglobin levels, discontinuation rates, subject satisfaction, and cycle-related symptoms and work productivity at baseline.
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Registry information
Official study title
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg in a Continuous Daily Regimen for Oral Contraception
Important dates
- Study start
- 2003
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Oct 28, 2005
- Registry last updated
- Feb 8, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121
Contraception
Mobile, Alabama, United States
View Trial DetailsPilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception
NCT03067272
Contraception
New York, United States
View Trial DetailsIntervening on Women's Health for Rural Young Cancer Survivors
NCT06664034
Cancer, Contraception
Brawley, California, United States
View Trial DetailsThe HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
NCT05818254
Autoimmune Diseases, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial Details